News | Artificial Intelligence | June 08, 2018

Company also announces completion of $30M C round of financing

Zebra Medical Vision Unveils AI-Based Chest X-ray Research

June 8, 2018 — Zebra Medical Vision unveiled its Textray chest X-ray research, which will form the basis for a future artificial intelligence (AI)-based automated chest X-ray analysis product the company is developing. Simultaneously, the company announced it has raised $30M in C round funding, bringing the total investment in the company to $50M.

This round of investment is led by aMoon Ventures, with the participation of strategic healthcare investors Aurum, Johnson & Johnson Innovation JJDC Inc. and Intermountain Healthcare, and leading global AI scientists Prof. Fei Fei Lee and Richard Socher. These new investors are joining a list of existing investors that includes Khosla Ventures, NVIDIA, Marc Benioff, OurCrowd and Dolby Ventures, who also participated in this C round.

The chest X-ray AI analytics product was trained using nearly 2 million images to identify 40 different common clinical findings. The results of the study demonstrate high rates of agreement between the algorithm and human radiologist experts.

Zebra Medical Vision has received the CE regulatory mark for seven of its products, as well as approvals in numerous countries across Latin America and Asia. Its most recent announcements were the CE approval of computed tomography (CT) brain bleed and mammography lesion detection algorithms. The company’s current and future arsenal of AI algorithms is bundled into a unique $1 per scan offering to hospitals, in order to provide scalable, transparent and affordable care solutions.

“Medical experts worldwide are facing a critical challenge in handling overwhelming demand. We are excited to partner with the Zebra-Med team, which is harnessing the power of data and machine learning to provide physicians and healthcare systems with tools to dramatically increase capacity, while improving patient care," said Yair Schindel, M.D., managing partner at aMoon VC. “This investment aligns with our vision of backing scalable and sustainable innovations that will have a valuable impact on fundamental facets of global healthcare.”

For more information: www.zebra-med.com

Reference

Laserson J., Lantsman C.D., Cohen-Sfady M., et al. "TextRay: Mining Clinical Reports to Gain a Broad Understanding of Chest X-rays," arxiv.org, June 6, 2018. arXiv:1806.02121


Related Content

News | Interventional Radiology

May 12, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in ...

Time May 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

May 11, 2026 – At the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE ...

Time May 11, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

April 27, 2026 — SimonMed, one of the nation’s largest independent outpatient imaging providers, has announced the ...

Time May 04, 2026
arrow
News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | Artificial Intelligence

April 20, 2026 — DeepTek, provider of the Augmento platform and deepc, the company behind deepcOS, have introduced a ...

Time April 23, 2026
arrow
News | Computed Tomography (CT)

April 2, 2026 — Nano-X Imaging Ltd. recently announced its U.S.-based subsidiary, Nanox Impact Inc., has signed a new ...

Time April 08, 2026
arrow
News | Computed Tomography (CT)

April 2, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for True ...

Time April 03, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
Subscribe Now